IKS
Inventurus Knowledge Solutions Limited (IKS) Stock Analysis
Inventurus Knowledge Solutions Limited provides healthcare technology and revenue-cycle outsourcing to hospitals and providers, mainly in North America. It helps clients with billing, coding, and clinical documentation workflows. The company is an India-based listed health-tech services firm.
Healthcare › Health Information Services
₹1,731.40
+0.86% 1W | +13.90% 52W
Market Cap
29.0k CR
P/E Ratio
38.7
52W High
₹1970
52W Low
₹1262
Div. Yield
0%
Beta
–
50 DMA
₹1773.4
200 DMA
₹1652.7
Profit Margin
22.8%
Inst. Own.
9.9%
📈 CONSOLIDATING UP
📈 CONSOLIDATING UP
Fundamentals
Profit & Loss
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 567 | 620 | 640 | 643 | 657 | 724 | 740 | 781 | 815 | 858 | 894 |
| Expenses | 405 | 494 | 467 | 454 | 476 | 498 | 502 | 511 | 536 | 563 | 604 |
| Operating Profit | 162 | 126 | 173 | 189 | 181 | 226 | 238 | 270 | 279 | 295 | 290 |
| OPM % | 29% | 20% | 27% | 29% | 28% | 31% | 32% | 35% | 34% | 34% | 32% |
| Other Income | 6 | 15 | 4 | 5 | 27 | 3 | 3 | 4 | 6 | 5 | 6 |
| Interest | 26 | 32 | 26 | 22 | 21 | 21 | 18 | 16 | 23 | 13 | 10 |
| Depreciation | 19 | 27 | 28 | 28 | 28 | 28 | 28 | 30 | 32 | 34 | 34 |
| Profit before tax | 124 | 81 | 122 | 144 | 160 | 180 | 195 | 228 | 229 | 253 | 251 |
| Tax % | 18% | 21% | 22% | 21% | 19% | 18% | 22% | 21% | 20% | 19% | 23% |
| Net Profit | 102 | 64 | 95 | 113 | 130 | 148 | 152 | 181 | 183 | 206 | 194 |
| EPS in Rs | 5.94 | 3.72 | 5.57 | 6.59 | 7.56 | 8.61 | 8.83 | 10.53 | 10.68 | 12.00 | 11.29 |
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 529 | 553 | 764 | 1,031 | 1,818 | 2,664 | 3,194 | 3,347 |
| Expenses | 367 | 348 | 466 | 639 | 1,297 | 1,893 | 2,110 | 2,213 |
| Operating Profit | 162 | 205 | 298 | 392 | 521 | 771 | 1,084 | 1,134 |
| OPM % | 31% | 37% | 39% | 38% | 29% | 29% | 34% | 34% |
| Other Income | 31 | 16 | 1 | -2 | 40 | 39 | 17 | 20 |
| Interest | 7 | 8 | 7 | 6 | 61 | 91 | 72 | 62 |
| Depreciation | 40 | 30 | 23 | 25 | 59 | 113 | 124 | 131 |
| Profit before tax | 145 | 183 | 269 | 359 | 442 | 606 | 905 | 961 |
| Tax % | 5% | 9% | 13% | 15% | 16% | 20% | 20% | |
| Net Profit | 137 | 165 | 233 | 305 | 370 | 486 | 722 | 764 |
| EPS in Rs | 8.33 | 10.00 | 13.61 | 17.86 | 21.68 | 28.33 | 42.03 | 44.50 |
| Dividend Payout % | 0% | 12% | 393% | 55% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 46.0% | 42.0% | – |
| Profit CAGR | 30.0% | 34.0% | – |
Shareholding Pattern
Promoters63.72%
FIIs6.50%
DIIs4.33%
Public22.88%
Promoters63.72%
FIIs7.02%
DIIs4.89%
Public21.90%
Promoters63.72%
FIIs7.56%
DIIs6.06%
Public20.29%
Promoters63.72%
FIIs8.19%
DIIs6.40%
Public19.39%
Promoters63.72%
FIIs8.01%
DIIs7.50%
Public18.55%
Promoters63.72%
FIIs5.38%
DIIs4.02%
Public24.29%
Promoters63.72%
FIIs8.19%
DIIs6.40%
Public19.39%
Promoters63.72%
FIIs8.01%
DIIs7.50%
Public18.55%
IKS
Holdings Analysis
Key strengths & risk signals
79
Overall
82
Fundamental
76
Technical
Risks (3)
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
RECOVERY MODE! Current price (1731.4) above 200-day but below 50-day.
WEAK MOMENTUM! Limited price growth - 0.9% (1 week), -1.2% (1 month), -8.7% (3 months).
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (1773.4) is above 200-day average (1652.7) - positive signal.
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 262,216 vs down days: 138,267. Ratio: 1.9x
UPPER HALF! Trading at 66.3% of 52W range - positive territory.
Fundamental & Technical Analysis
79Overall
82Fundamental
76Technical
Fundamental Breakdown
Growth Quality
30/30
Revenue CAGR: 45.8% (EXCELLENT, 15/15). Profit CAGR: 33.2% (EXCELLENT, 15/15).
Profit Margin
8/10
EXCELLENT EFFICIENCY! 22.8% profit margin - company keeps strong profits.
PEG Valuation
9/10
FAIRLY VALUED! PEG of 1.17 indicates reasonable valuation.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
8/10
LOW DEBT! D/E of 0.48 - strong balance sheet.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 23.52% public ownership - balanced ownership structure.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (1773.4) is above 200-day average (1652.7) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (1731.4) above 200-day but below 50-day.
Trend Pattern
14/20
Current trend: CONSOLIDATING UP
52W Performance
6/10
POSITIVE YEAR! Stock gained 13.9% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 262,216 vs down days: 138,267. Ratio: 1.9x
RSI
3/5
NEUTRAL! RSI at 45.2 - balanced momentum.
52W Range
4/5
UPPER HALF! Trading at 66.3% of 52W range - positive territory.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - 0.9% (1 week), -1.2% (1 month), -8.7% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
IKS
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-11 | Concall PDF | |
| Q4FY262026-05-20 | Concall PDF | |
| Q3FY262026-02-11 | Concall PDF | |
| Q2FY262025-11-06 | Concall PDF |
Peer Comparison
Healthcare · Health Information Services · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IKS | ₹1,731.40 | 38.7 | 22.8% | 45.8% | 33.2% | +13.9% | 79 | CONSOLIDATING UP | +27.9% | -6.0% | +20.7% | +4.2% |
| SAGILITY | ₹45.30 | 21.4 | 13.0% | 19.5% | 86.1% | -0.5% | 77 | APPROACHING RESISTANCE | +45.9% | -15.9% | +27.6% | -3.0% |
| INDGN | ₹598.30 | 36 | 10.5% | 15.0% | 14.7% | +10.0% | 69 | APPROACHING SUPPORT | -0.2% | +45.8% | +39.7% | +5.9% |
| FABTECH | ₹130.30 | 10.6 | 11.7% | 28.3% | 20.8% | -26.4% | 65 | BREAKDOWN | -168.9% | -81.0% | +10.3% | -52.7% |
| TAKE | ₹12.60 | 32.3 | 15.2% | -34.1% | – | -41.5% | 38 | CONSOLIDATING DOWN | -283.3% | -75.0% | – | -43.9% |
| KIMS | ₹685.60 | 134.4 | 4.8% | 21.3% | -10.5% | -4.3% | 58 | BREAKDOWN | -47.2% | -2.4% | +35.3% | +9.8% |
| SAILIFE | ₹1,389.40 | 82.1 | 16.1% | 21.3% | 226.9% | +60.0% | 70 | BREAKDOWN | +21.2% | -29.7% | +11.7% | -7.9% |
| LALPATHLAB | ₹1,859.90 | 57.4 | 18.7% | 11.1% | 28.3% | +24.7% | 87 | BREAKDOWN | +28.0% | +29.1% | +19.1% | +13.5% |
Data from TradeAlone · Updated daily
IKS News
Inventurus Knowledge Solutions Limited (NSE: IKS) falls 5% intraday2026-08-06Inventurus Knowledge Solutions Limited (NSE: IKS) extends gains, moves up 5% intraday2026-07-31Inventurus Knowledge Solutions Limited (IKS) Completes Acquisition of Trubridge2026-07-09Inventurus Knowledge Solutions Limited (IKS) breaks out, gains 5% intraday2026-07-01Inventurus Knowledge Solutions Limited (iks): IKS Health Delivers $12 Million Annual Cash Impact for Axia Women’s Health2026-06-30Inventurus Knowledge Solutions Limited (IKS) Reports Robust FY26 Financial Results with 20% Revenue Growth2026-05-13IKS Health and Holyoke Medical Center Partner to Cut Administrative Burden2026-05-05
